Showing results (71-80 of 84) with videos related to
Sort By:
Pageof 9
Journal of Neurogastroenterology and Motility|June 11, 2019
Association Between Gastric Emptying Time and Incidence of Cardiovascular Diseases in Subjects With DiabetesHyung-Min Park, Seon-Young Park, Jin Ook Chung, et al.Yonsei Medical Journal|May 19, 2016
Assessment of Denosumab in Korean Postmenopausal Women with Osteoporosis: Randomized, Double-Blind, Placebo-Controlled Trial with Open-Label ExtensionJung Min Koh, Dong Jin Chung, Yoon Sok Chung, et al.Yonsei Medical Journal|May 19, 2016
Vitamin D Repletion in Korean Postmenopausal Women with OsteoporosisYoon Sok Chung, Dong Jin Chung, Moo Il Kang, et al.The Korean Journal of Internal Medicine|September 27, 2002
Prevalence of diabetes mellitus in the elderly of Namwon County, South KoreaSang Guk Kim, Seung Won Yang, An Soo Jang, et al.Diabetes & Metabolism Journal|June 20, 2022
Safety and Effectiveness of Empagliflozin in Korean Patients with Type 2 Diabetes Mellitus: Results from a Nationwide Post-Marketing SurveillanceJun Sung Moon, Nam Hoon Kim, Jin Oh Na, et al.Korean Journal of Radiology|August 28, 2024
Local Ablation for Hepatocellular Carcinoma: 2024 Expert Consensus-Based Practical Recommendations of the Korean Liver Cancer AssociationSeungchul Han, Pil Soo Sung, Soo Young Park, et al.Journal of Liver Cancer|August 30, 2024
Local ablation for hepatocellular carcinoma: 2024 expert consensus-based practical recommendation of the Korean Liver Cancer AssociationSeungchul Han, Pil Soo Sung, Soo Young Park, et al.Gut and Liver|September 2, 2024
Local Ablation for Hepatocellular Carcinoma: 2024 Expert Consensus-Based Practical Recommendations of the Korean Liver Cancer AssociationSeungchul Han, Pil Soo Sung, Soo Young Park, et al.Diabetes & Metabolism Journal|April 22, 2016
Comparison of Vildagliptin and Pioglitazone in Korean Patients with Type 2 Diabetes Inadequately Controlled with MetforminJong Ho Kim, Sang Soo Kim, Hong Sun Baek, et al.Calcified Tissue International|October 10, 2009
Comparison of monthly ibandronate versus weekly risedronate in preference, convenience, and bone turnover markers in Korean postmenopausal osteoporotic womenYoon-Sok Chung, Sung-Kil Lim, Ho-Yeon Chung, et al.Pageof 9